NEW YORK (GenomeWeb News) – Illumina today said researchers from Massachusetts General Hospital and Harvard Medical School will use data from its Sentrix HumanHap300 BeadChips and Infinium assay reagents to run a whole-genome association study of amyotrophic lateral sclerosis.
 
The 2,200-sample case/control study is the largest genetic study to date of ALS, according to study co-supervisor Adrian Ivinson, director of Harvard’s Center for Neurodegeneration and Repair.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.